中华实验和临床病毒学杂志
中華實驗和臨床病毒學雜誌
중화실험화림상병독학잡지
CHINESE JOURNAL OF EXPERIMENTAL AND CLINICAL VIROLOGY
2001年
1期
20-23
,共4页
高建恩%陶其箴%马大龙%冯百芳%纪和平%季颖
高建恩%陶其箴%馬大龍%馮百芳%紀和平%季穎
고건은%도기잠%마대룡%풍백방%기화평%계영
肝炎病毒,丙型%基因表达%病毒包膜蛋白%质粒
肝炎病毒,丙型%基因錶達%病毒包膜蛋白%質粒
간염병독,병형%기인표체%병독포막단백%질립
目的在原核表达系统中对HCV E1基因进行克隆和高效表达,并初步探讨表达产物在抗-HCV筛选中的作用。方法通过RT-PCR法从HCV RNA阳性的血清标本中扩增出HCV EI片段,并在扩增用的引物中引入克隆所需的酶切位点,克隆产物经Xba I和EeoR I酶切后,在T4DNA连接酶的作用下克降入经同样双酶切的原核表达载体PMS-31b中,并用此连接产物转化大肠埃希菌POP2136,挑取具有氨苄抗性的菌落扩大培养后提取质粒进行酶切鉴定,鉴定出的阳性菌经42℃诱导后用SDS-PAGE检查其表达状况,并用Western blot鉴定表达产物的特异性,同时用初步纯化的表达产物用ELISA法检测病人血清。结果经Sma I酶切后PCR产物被切成144 bp和356 bp的两个片段,在具有氨苄抗性的菌中提取的质粒经Sma I和Xba I酶切后产生了一356 bp的片段;42℃诱导后在SDS-PAGE中出现了一条相对分子质量为31 000的条带,其表达量约为17%,经West-ern blot鉴定后在该处出现了阳性信号;ELISA实验显示在抗HCV阳性的血清中的阳性率约为29.8%(26/90),而在抗HCV阴性的血清中其阳性率约为3.9%(3/76)。结论通过RT-PCR方法将HCV E1基因从HCV RNA阳性的血清标本中调出,构建了HCV E1的原核表达载体-PMS-E1,其表达量为17%,表达产物具有良好的特异性,有望应用于抗HCV的检测中。
目的在原覈錶達繫統中對HCV E1基因進行剋隆和高效錶達,併初步探討錶達產物在抗-HCV篩選中的作用。方法通過RT-PCR法從HCV RNA暘性的血清標本中擴增齣HCV EI片段,併在擴增用的引物中引入剋隆所需的酶切位點,剋隆產物經Xba I和EeoR I酶切後,在T4DNA連接酶的作用下剋降入經同樣雙酶切的原覈錶達載體PMS-31b中,併用此連接產物轉化大腸埃希菌POP2136,挑取具有氨芐抗性的菌落擴大培養後提取質粒進行酶切鑒定,鑒定齣的暘性菌經42℃誘導後用SDS-PAGE檢查其錶達狀況,併用Western blot鑒定錶達產物的特異性,同時用初步純化的錶達產物用ELISA法檢測病人血清。結果經Sma I酶切後PCR產物被切成144 bp和356 bp的兩箇片段,在具有氨芐抗性的菌中提取的質粒經Sma I和Xba I酶切後產生瞭一356 bp的片段;42℃誘導後在SDS-PAGE中齣現瞭一條相對分子質量為31 000的條帶,其錶達量約為17%,經West-ern blot鑒定後在該處齣現瞭暘性信號;ELISA實驗顯示在抗HCV暘性的血清中的暘性率約為29.8%(26/90),而在抗HCV陰性的血清中其暘性率約為3.9%(3/76)。結論通過RT-PCR方法將HCV E1基因從HCV RNA暘性的血清標本中調齣,構建瞭HCV E1的原覈錶達載體-PMS-E1,其錶達量為17%,錶達產物具有良好的特異性,有望應用于抗HCV的檢測中。
목적재원핵표체계통중대HCV E1기인진행극륭화고효표체,병초보탐토표체산물재항-HCV사선중적작용。방법통과RT-PCR법종HCV RNA양성적혈청표본중확증출HCV EI편단,병재확증용적인물중인입극륭소수적매절위점,극륭산물경Xba I화EeoR I매절후,재T4DNA련접매적작용하극강입경동양쌍매절적원핵표체재체PMS-31b중,병용차련접산물전화대장애희균POP2136,도취구유안변항성적균락확대배양후제취질립진행매절감정,감정출적양성균경42℃유도후용SDS-PAGE검사기표체상황,병용Western blot감정표체산물적특이성,동시용초보순화적표체산물용ELISA법검측병인혈청。결과경Sma I매절후PCR산물피절성144 bp화356 bp적량개편단,재구유안변항성적균중제취적질립경Sma I화Xba I매절후산생료일356 bp적편단;42℃유도후재SDS-PAGE중출현료일조상대분자질량위31 000적조대,기표체량약위17%,경West-ern blot감정후재해처출현료양성신호;ELISA실험현시재항HCV양성적혈청중적양성솔약위29.8%(26/90),이재항HCV음성적혈청중기양성솔약위3.9%(3/76)。결론통과RT-PCR방법장HCV E1기인종HCV RNA양성적혈청표본중조출,구건료HCV E1적원핵표체재체-PMS-E1,기표체량위17%,표체산물구유량호적특이성,유망응용우항HCV적검측중。
Objective To express the HCV E1 gene in E. coli cells and to demonstrate its cli.nical significance in detection of anti-HCV E1 antibodies. Methods The expression vector was constructed by ligation of HCV E1 sequence, which was amplified by RT-PCR methods from 50 μl of HCV RNA positive serum using primers specific to the HCV E1 sequence, to the prokaryotic expression vector PMS-31b transfected POP2136 at 16 ℃ for 16 hours. The recombinant plasmid was screened out and characterized by restriction enzyme analysis. The bacteria containing the recombinant plasmid was induced at 42 ℃ for 4 hours, and the recombinant protein was visualized by SDS-PAGE. The specificity of the recombinant protein was determined by Western blot assay. After purification of the expressed protein, this protein was coated on the plate with the concentration of 2μg/ml in pH 9.6 buffer at 4 ℃ for overnight,and the serum specimen was tested at the dilution of 1: 20 by ELISA. Results There were 2 fragments could be seen on the SDSPAGE after digestion of the RT-PCR product with Sma I And there emerged one fragment of 356 bp af ter digesting the recombinant plasmid with Sma I and Xba I A band of 30 000 could be seen on the SDS-PAGE after the induction of bacteria containing the recombinant plasmid pMS-E1 at 42 ℃ for 4 hours. The Western blot assay showed that the expressed band could react with the anti-HCV positive serum. The ELISA result indicated that there were 28.9% (26/90) anti-HCV positive serum were antiHCV E1 positive, but 3.9 % (3/76) were positive in the anti-HCV negative serum. Conclusion The HCV El sequence from HCV RNA positive serum has been expresed in E. coli. The expression rate is about 179% of the total protein of the bacteria. This protein possessed good specificity and may be used in the diagnosis of HCV infection.